Since the Global Fund’s Indirect Cost Recovery (ICR) policy was adopted on 18 April 2011, a number of concerns have been raised about the interpretation and application of the policy. This article describes the concerns and provides responses from the Global Fund Secretariat.
As of 31 December of 2012, donors had pledged $10.4 billion for the 2011–2013 replenishment period. This is a 13% increase over the $9.2 billion pledged at the actual replenishment conference in October 2010.
The difference comes primarily from pledges made following the New York conference. A group of donors, including Belgium, Netherlands, Saudi Arabia and Sweden, announced their pledges after the conference.
In preparation for the Fourth Replenishment meetings, the Global Fund has a published an “Update on Results and Impact.” This article provides some of the highlights of the report; more details are provided in separate articles on each of the three diseases.
The Global Fund will conduct a process evaluation of the transition phase of the new funding model (NFM) to enable the Fund to draw some conclusions and make adjustments for the full rollout of the NFM.
This information was contained in the Global Fund’s “Update on Results and Impact” report published on the eve of the Fund’s pre-replenishment meeting in Brussels, Belgium on 9–10 April.
Changes to the charter of the Office of the Inspector General (OIG) adopted by the Global Fund Board specify that when the OIG conducts country audits, it will not evaluate programme impact.
From now on, annual disbursement decisions and semi-annual reporting will be adopted for all Global Fund grants. The only exception will be for grants whose risk profile requires shorter disbursement decisions or more frequent reporting.
These are part of the changes introduced in February 2013 as part of the Global Fund’s Better Grants for Improved Impact Project.
The Global Fund Board has appointed Dr Nafsiah Mboi, Minister of Health in Indonesia, as the next Chair of the Board. It has also appointed Mireille Guigaz as the next Vice-Chair. Ms Guigaz currently represents France on the Board. Dr Mboi does not currently sit on the Board. Both appointments are effective at the end of the 29th Board meeting in June 2013; the two terms will run until the end of the first Board meeting in 2015.
The Eurasian Harm Reduction Network has released a policy brief on “The Global Fund’s New Funding Model: What It Might Mean for You and Your Country.” The brief is based on research in four countries in Eastern Europe and Central Asia (EECA): Armenia, Georgia, Moldova and Uzbekistan.
Global Fund Executive Director Mark Dybul says that the disease split for the funding allocated to early and interim applicants in the transition phase of the new funding model (NFM) should not be viewed in isolation, but rather in the context of all funding for 2013–2014.